急性ST段抬高型心肌梗死多支病变血运重建的策略与时机

章思铖; 张立炜; 罗蔓青; 林雪琴; 林开阳; 郭延松

doi:10.13201/j.issn.1001-1439.2022.07.003

急性ST段抬高型心肌梗死多支病变血运重建的策略与时机

- 1.
  福建医科大学省立临床医学院(福州，350001)
- 2.
  福建省立医院心内三科
基金项目:
国家自然科学基金项目(No: 81873495)

详细信息

通讯作者: 郭延松，E-mail：ysguo1234@126.com

中图分类号: R541.4

收稿日期: 2021-10-12

刊出日期: 2022-07-13

Improving strategy and timing of revascularization in acute ST-segment elevation myocardial infarction with multi-vessel disease

- 1.
  Shengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China
- 2.
  Department of Cardiology, Fujian Provincial Hospital

More Information

Corresponding author: GUO Yansong, E-mail: ysguo1234@126.com

Received Date: 12 October 2021

Publish Date: 13 July 2022

摘要

摘要: 急性ST段抬高型心肌梗死(STEMI)为冠心病最严重的类型，40%~70%的患者存在多支血管病变，致死和致残率高。与单支血管病变的STEMI患者相比，合并多支血管病变的患者心血管不良事件的发生率明显增加。由于多支血管病变中的非罪犯血管病理生理状态相对特殊，选择合适的血运重建策略和时机可能对于改善预后具有积极意义。合并多支血管病变的STEMI患者，是仅对罪犯血管行急诊经皮冠状动脉介入治疗，还是在处理罪犯血管的同时或择期对非罪犯血管行完全血运重建，一直是急诊介入治疗领域存在争议的话题之一。本文主要针对合并多支血管病变的STEMI患者血运重建的策略与时机的研究进展作一综述。
- 急性ST段抬高型心肌梗死 /
- 多支血管病变 /
- 血运重建 /
- 经皮冠状动脉介入治疗
Abstract: ST-segment elevation myocardial infarction (STEMI) is the most severe type of coronary heart disease. About 40% to 70% of STEMI patients have multi-vessel disease, resulting in high mortality and disability. Compared to single-vessel disease patients, multi-vessel disease patients have a significantly increased incidence of adverse cardiovascular events. Considering the status of non-criminal vessels, we think that appropriate strategy and timing for revascularization may have positive value for improving prognosis. Whether to perform emergency percutaneous coronary intervention (PCI) only for criminal vessels or perform complete revascularization for both criminal and non-criminal vessels at the same time or at an elective time, is controversial in emergency interventional therapy. This article reviews the research progress on the strategy and timing of revascularization in acute ST-segment elevation myocardial infarction with multi-vessel disease.
- acute st-segment elevation myocardial infarction /
- multi-vessel disease /
- revascularization /
- percutaneous coronary intervention

HTML全文

参考文献(56)

[1]	Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials[J]. Lancet, 2003, 361(9351): 13-20. doi: 10.1016/S0140-6736(03)12113-7
[2]	Huynh T, Perron S, O'Loughlin J, et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies[J]. Circulation, 2009, 119(24): 3101-3109. doi: 10.1161/CIRCULATIONAHA.108.793745
[3]	O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions[J]. Catheter Cardiovasc Interv, 2013, 82(1): E1-E27. doi: 10.1002/ccd.24776
[4]	李云曌, 吴辉, 刘滴. 急性心肌梗死合并心源性休克诊治进展[J]. 临床心血管病杂志, 2020, 36(8): 692-695. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202008003.htm
[5]	Park DW, Clare RM, Schulte PJ, et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction[J]. JAMA, 2014, 312(19): 2019-2027. doi: 10.1001/jama.2014.15095
[6]	蒋俊, 史雷忠, 谢鹏程, 等. 外周血嗜酸粒细胞百分率联合高敏C反应蛋白对ST段抬高型心肌梗死患者PCI术后院内主要不良心脏事件的预测价值[J]. 临床急诊杂志, 2020, 21(12): 954-959. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202012005.htm
[7]	Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2018, 39(2): 119-177. doi: 10.1093/eurheartj/ehx393
[8]	李末寒, 冯城婷, 吴云. 急性ST段抬高型心肌梗死患者短期不良预后列线图的构建[J]. 临床急诊杂志, 2021, 22(4): 256-260. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202104007.htm
[9]	Bagai A, Thavendiranathan P, Sharieff W, et al. Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis[J]. Am Heart J, 2013, 166(4): 684-693. e1. doi: 10.1016/j.ahj.2013.07.027
[10]	Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J]. J Am Coll Cardiol, 2016, 67(10): 1235-1250. doi: 10.1016/j.jacc.2015.10.005
[11]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-783. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXX201504001.htm
[12]	Roe MT, Cura FA, Joski PS, et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction[J]. Am J Cardiol, 2001, 88(2): 170-173, A6. doi: 10.1016/S0002-9149(01)01615-0
[13]	Panaich SS, Arora S, Patel N, et al. Comparison of In-Hospital Mortality, Length of Stay, Postprocedural Complications, and Cost of Single-Vessel Versus Multivessel Percutaneous Coronary Intervention in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction(from Nationwide Inpatient Sample[2006 to 2012])[J]. Am J Cardiol, 2016, 118(7): 950-958. doi: 10.1016/j.amjcard.2016.06.057
[14]	Toma M, Buller CE, Westerhout CM, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial[J]. Eur Heart J, 2010, 31(14): 1701-1707. doi: 10.1093/eurheartj/ehq129
[15]	Iqbal MB, Ilsley C, Kabir T, et al. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London[J]. Circ Cardiovasc Qual Outcomes, 2014, 7(6): 936-943. doi: 10.1161/CIRCOUTCOMES.114.001194
[16]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(5): 380-393. https://www.cnki.com.cn/Article/CJFDTOTAL-GWXX201504001.htm
[17]	Wald DS, Morris JK, Wald NJ, et al. Randomized trial of preventive angioplasty in myocardial infarction[J]. N Engl J Med, 2013, 369(12): 1115-1123.
[18]	Gershlick AH, Khan JN, Kelly DJ, et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial[J]. J Am Coll Cardiol, 2015, 65(10): 963-972.
[19]	Politi L, Sgura F, Rossi R, et al. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up[J]. Heart, 2010, 96(9): 662-667.
[20]	Ghani A, Dambrink JH, van 't Hof AW, et al. Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial[J]. Neth Heart J, 2012, 20(9): 347-353.
[21]	Engstrøm T, Kelbæk H, Helqvist S, et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease(DANAMI-3—PRIMULTI): an open-label, randomised controlled trial[J]. Lancet, 2015, 386(9994): 665-671.
[22]	Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction[J]. N Engl J Med, 2017, 376(13): 1234-1244.
[23]	Mehta SR, Wood DA, Storey RF, et al. Complete Revascularization with Multivessel PCI for Myocardial Infarction[J]. N Engl J Med, 2019, 381(15): 1411-1421.
[24]	Elgendy IY, Mahmoud AN, Kumbhani DJ, et al. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials[J]. JACC Cardiovasc Interv, 2017, 10(4): 315-324.
[25]	Pavasini R, Biscaglia S, Barbato E, et al. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials[J]. Eur Heart J, 2020, 41(42): 4103-4110.
[26]	Bainey KR, Engstrøm T, Smits PC, et al. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis[J]. JAMA Cardiol, 2020, 5(8): 881-888.
[27]	Members WC, Lawton JS, Tamis-Holland JE, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol, 2021, 79(2): e21-e129.
[28]	Ochala A, Smolka GA, Wojakowski W, et al. The function of the left ventricle after complete multivessel one-stage percutaneous coronary intervention in patients with acute myocardial infarction[J]. J Invasive Cardiol, 2004, 16(12): 699-702.
[29]	Fatima U, Khan SU, Akanbi O, et al. Network Meta-Analysis of Percutaneous Intervention-Based Revascularization Strategies for ST-Elevation Myocardial Infarction and Concomitant Multi-Vessel Disease[J]. Cardiovasc Revasc Med, 2019, 20(7): 603-611.
[30]	Cerrud-Rodriguez RC, Rashid S, Wiley KA, et al. Complete Revascularization of Stable STEMI Patients Offers a Significant Benefit if Done During the Index PCI, but Not if It's Done as a Staged Procedure[J]. Int J Gen Med, 2021, 14: 2239-2248.
[31]	Corpus RA, House JA, Marso SP, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction[J]. Am Heart J, 2004, 148(3): 493-500.
[32]	Doǧan C, Bayram Z, Çap M, et al. Comparison of 30-Day MACE between Immediate versus Staged Complete Revascularization in Acute Myocardial Infarction with Multivessel Disease, and the Effect of Coronary Lesion Complexity[J]. Medicina(Kaunas), 2019, 55(2): 100.
[33]	Kornowski R, Mehran R, Dangas G, et al. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI(harmonizing outcomes with revascularization and stents in acute myocardial infarction)trial[J]. J Am Coll Cardiol, 2011, 58(7): 704-711.
[34]	Tarasov RS, Ganyukov VI, Protopopov AV, et al. Results of a Randomized Study: Multivessel Stenting and Staged Revascularization in Patients With ST-Elevation Myocardial Infarction Using Second Generation Drug Covered Stents[J]. Kardiologiia, 2017, 57(3): 25-30.
[35]	Kim I, Kim MC, Jeong HC, et al. Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease[J]. Korean Circ J, 2017, 47(1): 36-43.
[36]	Zhao XD, Zhao GQ, Wang X, et al. Optimal timing of staged percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with multivessel disease[J]. J Geriatr Cardiol, 2018, 15(5): 356-362.
[37]	Fortuni F, Crimi G, Angelini F, et al. Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease[J]. Can J Cardiol. 2019, 35(8): 1047-1057.
[38]	Otsuka T, Bär S, Losdat S, et al. Effect of Timing of Staged Percutaneous Coronary Intervention on Clinical Outcomes in Patients With Acute Coronary Syndromes[J]. J Am Heart Assoc, 2021, 10(23): e023129.
[39]	魏宇淼. 急性心肌梗死并发心源性休克的当代治疗策略及技术[J]. 临床心血管病杂志, 2021, 37(7): 591-594. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202107001.htm
[40]	Samsky MD, Morrow DA, Proudfoot AG, et al. Cardiogenic Shock After Acute Myocardial Infarction: A Review[J]. JAMA, 2021, 326(18): 1840-1850.
[41]	Thiele H, Akin I, Sandri M, et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock[J]. N Engl J Med, 2017, 377(25): 2419-2432.
[42]	Thiele H, Akin I, Sandri M, et al. One-Year Outcomes after PCI Strategies in Cardiogenic Shock[J]. N Engl J Med, 2018, 379(18): 1699-1710.
[43]	Lee JM, Rhee TM, Hahn JY, et al. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock[J]. J Am Coll Cardiol, 2018, 71(8): 844-856.
[44]	Henriques J, Claessen BE. Revascularization Strategies in Cardiogenic Shock Patients With MVD: For Now, Keep it Simple[J]. J Am Coll Cardiol, 2018, 71(8): 857-859.
[45]	Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock(IABP-SHOCK Ⅱ): final 12 month results of a randomised, open-label trial[J]. Lancet, 2013, 382(9905): 1638-1645.
[46]	Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI[J]. N Engl J Med, 2017, 376(19): 1824-1834.
[47]	Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI[J]. N Engl J Med, 2017, 376(19): 1813-1823.
[48]	Puymirat E, Cayla G, Simon T, et al. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction[J]. N Engl J Med, 2021, 385(4): 297-308.
[49]	Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention[J]. N Engl J Med, 2009, 360(3): 213-224.
[50]	Zhang J, Gao X, Kan J, et al. Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial[J]. J Am Coll Cardiol, 2018, 72(24): 3126-3137.
[51]	Ali ZA, Maehara A, Généreux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIEN Ⅲ: OPTIMIZE PCI): a randomised controlled trial[J]. Lancet, 2016, 388(10060): 2618-2628.
[52]	Kubo T, Shinke T, Okamura T, et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention(OPINION trial): one-year angiographic and clinical results[J]. Eur Heart J, 2017, 38(42): 3139-3147.
[53]	Meneveau N, Souteyrand G, Motreff P, et al. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study(Does Optical Coherence Tomography Optimize Results of Stenting)[J]. Circulation, 2016, 134(13): 906-917.
[54]	Kornowski R, Mehran R, Satler LF, et al. Procedural results and late clinical outcomes following multivessel coronary stenting[J]. J Am Coll Cardiol, 1999, 33(2): 420-426.
[55]	Stähli BE, Varbella F, Schwarz B, et al. Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease[J]. Am Heart J, 2020, 228: 98-108.
[56]	den Dekker WK, Van Mieghem NM, Bennett J, et al. Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trial[J]. Am Heart J, 2020, 227: 111-117.